gimli
GKSL stock analysis context
GUJARAT KIDNEY N SUP SP L Stock Context for AI Screening
GUJARAT KIDNEY N SUP SP L is a small-cap stock in Healthcare. This page summarizes key screening signals for GUJARAT KIDNEY N SUP SP L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive GKSL stock pagePrice
₹132.58
1W return
-5.90%
1M return
+5.88%
3M return
+20.09%
6M return
n/a
1Y return
n/a
Market cap
₹1,045.30 cr
PE
52.66
PB
21.64
ROE
n/a
ROCE
n/a
RSI
50.25
Turnover
₹2.12 cr
Why it can matter in screens
- Momentum: GKSL is above 50DMA; RSI is 50.25.
- Returns: 1D -1.24%, 1W -5.90%, 1M +5.88%, 3M +20.09%, 1Y n/a.
- Trend levels: 52W high ₹143.33, 52W low ₹99.36, off high -7.50%.
- Liquidity: latest turnover is ₹2.12 cr; volume vs 20D is +0.21%.
- Valuation/profitability: PE 52.66, PB 21.64, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-12-31 | 23.25 cr | 6.96 cr | 2.94 cr | 0.52 |
| 2025-06-30 | 31.09 cr | 13.66 cr | 7.80 cr | 0.99 |
| 2025-03-31 | 89.51 cr | 15.26 cr | 6.61 cr | nan |
| 2024-12-31 | 11.79 cr | 4.65 cr | 2.50 cr | 0.32 |
Annual income statement
No recent data available.
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-06-30 | 99.36 cr | 5.47 cr | 21.25 cr | 48.31 cr |
| 2025-03-31 | 91.29 cr | 4.58 cr | 22.77 cr | 39.83 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-12-31 | n/a | n/a | n/a |
| 2025-06-30 | 0.47 cr | 0.41 cr | n/a |
| 2025-03-31 | n/a | n/a | n/a |
| 2024-12-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +71.45% | +4.88% | +0.56% | +0.00% | +23.10% | +100.00% |
| 2025-12-31 | +71.45% | +10.47% | +1.67% | +0.00% | +16.40% | +100.00% |
| 2025-12-29 | +71.45% | +13.09% | +7.84% | +0.00% | +7.62% | +100.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 429,121.06 cr | 40.824543 | +15.06% | +7.26% |
| DIVISLAB | DIVI S LABORATORIES LTD | 174,585.42 cr | 68.707369 | +17.81% | +0.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 147,849.87 cr | 68.354079 | +29.94% | +39.35% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 119,204.71 cr | 64.295958 | +23.21% | +21.70% |
| CIPLA | CIPLA LTD | 111,088.72 cr | 29.624450 | +12.91% | -6.65% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 108,331.15 cr | 21.874917 | +20.44% | +16.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 105,181.70 cr | 24.542479 | +13.88% | +1.20% |
| LUPIN | LUPIN LIMITED | 103,385.66 cr | 22.341869 | +29.22% | +15.72% |
Try these prompts
- Analyze GUJARAT KIDNEY N SUP SP L with valuation, momentum and industry peers
- Compare GKSL with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare GKSL with other Healthcare stocks
Data snapshot: 2026-06-03. Not investment advice.